Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
BEAM
BEAM
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
BEAM News
Prime Medicine Wins Ruling, Boosts Stock Performance
1h ago
stocktwits
Prime Medicine Gains 8% After Arbitration Win Against Beam Therapeutics
5h ago
seekingalpha
New CRISPR Technology Opens Opportunities in Biotech
7h ago
NASDAQ.COM
New CRISPR Technology Could Transform Market Dynamics
8h ago
Fool
Beam Therapeutics Receives FDA Clearance for Gene-Editing Therapy
Jun 19 2026
NASDAQ.COM
FDA Approves BEAM-304 for Transformative PKU Therapy Development
Jun 18 2026
Newsfilter
Avaí Bio Achieves Milestone in α-Klotho Cell Bank Development
May 28 2026
Newsfilter
Gene Editing Sector Gains Momentum with Key Players CRISPR and Beam
May 26 2026
Fool
Analysis of Gene Editing Industry Prospects
May 26 2026
NASDAQ.COM
ADAR1 Capital Management Acquires Stake in Beam Therapeutics
May 18 2026
Fool
AlphaDetect Partners with Beam Therapeutics to Enhance Alpha-1 Detection Efforts
May 13 2026
Newsfilter
AlphaDetect Partners with Beam Therapeutics to Enhance Detection Efforts
May 13 2026
PRnewswire
Beam Therapeutics Presents Updated Data on Risto-cel for Sickle Cell Disease
May 12 2026
Newsfilter
Jim Cramer's Insights on Multiple Stocks
Apr 29 2026
CNBC
Jim Cramer's Insights on Various Stocks
Apr 28 2026
CNBC
Gene Drive Technology as a Solution to Invasive Species
Apr 12 2026
Yahoo Finance
Show More News
